COMPARISON TOOL

Compare peptides

Half-life, dosing, mechanism, status — side by side. Select up to four compounds, or start from a preset.

Tesamorelin

Max 4 peptides

Property	Tesamorelin
Category	Growth
Type	Peptide
Mechanism	Stabilized GHRH analog
Status	FDA-approved
Dosing range	1–2 mg daily
Frequency	Once daily
Half-life	~26–38 minutes
Route	Subcutaneous
Onset	8–12 weeks (visceral fat)
Studied for	Visceral fat reduction Triglycerides Growth hormone release
Key risks	Joint pain Swelling Glucose increase Injection-site reactions
Storage	Refrigerated (2–8 °C); use within the pharmacy beyond-use date
Available at G1	Vials: 10 mgPens: Fragment Apex, TesaTrimShop →
Tools	Dosage calculator →

PROPERTY COMPARISON · RADAR

Editorial profile scores (0–10) for orientation — not clinical measurements.

TYPICAL DOSE RANGES

Tesamorelin1 mg – 2 mg

Typical per-dose range on a logarithmic scale. Your provider sets your dose.

For educational purposes only. Consult a licensed provider before starting any peptide protocol.